Simons P J, Delemarre F G, Jeucken P H, Drexhage H A
Department of Immunology, Erasmus University, Rotterdam, The Netherlands.
J Endocrinol. 1998 Apr;157(1):43-51. doi: 10.1677/joe.0.1570043.
Thyroid autoimmune reactions start with an accumulation of mainly dendritic cells in the thyroid. There is increasing evidence that, apart from being antigen-presenting cells, they are also able to control the growth and hormone synthesis of neighbouring endocrine cells. The questions thus arise: are dendritic cells accumulating in the pre-autoimmune thyroid in response to an altered proliferative or metabolic activity of thyrocytes, and do cytokines, monocyte chemoattractants, or both, have a role in their accumulation? We have investigated these questions in thyrocytes of the biobreeding diabetes-prone (BB-DP) rat in relation to the start of the intrathyroid accumulation of dendritic cells--that is, at about 9 weeks of age. BB-DP rats and Wistar rats (controls) were studied from 3 to 20 weeks of age. Hyperplastic goitre development was studied by assessing the thyroid weight and by measuring the number of thyrocyte nuclei per 0.01 mm2 thyroid section. In addition, the in situ expression of interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-alpha), monocyte-chemotactic protein-1 (MCP-1), and intercellular adhesion molecule-1 (ICAM-1) were studied by immunohistochemistry. The in vitro proliferative capacity of BB-DP and Wistar thyrocytes was measured by tritiated-thymidine ([3H]TdR) and bromodeoxyuridine (BrdU) incorporation into reconstituted, TSH- and non-TSH-stimulated, cultured thyroid follicles. Further in vitro studies consisted of measurement of the production of thyroxine (T4), triiodothyronine (T3), thyroglobulin, IL-6, TNF-alpha and MCP-1 by the thyroid follicles. BB-DP rats developed a small hyperplastic goitre between the ages of 9 and 12 weeks. The in vitro proliferative rate of thyrocytes isolated from hyperplastic BB-DP thyroids was significantly lower than that of Wistar thyrocytes. This phenomenon also occurred in follicles isolated from BB-DP rats before hyperplastic goitre development, which produced significantly less T4, but more T3, than did Wistar follicles of the same age. At the time of and after hyperplastic goitre development, BB-DP follicles exhibited altered metabolic behaviour and produced significantly more T4, but equal amounts of T3 compared with both Wistar follicles of the same age and follicles of younger BB-DP rats (both under basal conditions and TSH-stimulated). In vitro IL-6 production by these BB-DP thyroid follicles was also increased. There was no noteworthy difference in production of thyroglobulin and MCP-1 between BB-DP and Wistar follicles at any age. TNF-alpha was not produced by BB-DP or Wistar thyroid follicles. Immunohistochemistry revealed the expression of IL-6 by both BB-DP and Wistar thyroid follicle cells at all times of sampling. MCP-1 and TNF-alpha were expressed only when infiltrates were present in BB-DP thyroids (restricted to leucocytes, ages > 18 weeks). Modest ICAM-1 expression was restricted to large blood vessels in both BB-DP and Wistar thyroids; in the case of infiltrates (BB-DP rat) alone, high ICAM-1 expression was found on blood vessels and leucocytes in these infiltrations. At the time of intrathyroidal dendritic cells accumulation, BB-DP rats develop a small hyperplastic goitre. At that time there is also in vitro evidence for a shift to a higher production of thyroxine and IL-6 from thyrocyte follicles. The in vitro proliferation rate of BB-DP thyrocytes is, however, abnormally low (both in the pre- and hyperplastic period). Similar pre-autoimmune thyroid growth abnormalities have been described in another animal model of thyroid autoimmune disease, the obese strain chicken.
甲状腺自身免疫反应始于甲状腺中主要是树突状细胞的积累。越来越多的证据表明,除了作为抗原呈递细胞外,它们还能够控制邻近内分泌细胞的生长和激素合成。因此出现了以下问题:树突状细胞在自身免疫前期甲状腺中的积累是对甲状腺细胞增殖或代谢活动改变的反应吗?细胞因子、单核细胞趋化因子或两者在其积累过程中起作用吗?我们在生物繁殖糖尿病易感性(BB-DP)大鼠的甲状腺细胞中研究了这些问题,研究时间与甲状腺内树突状细胞开始积累的时间相关,即大约9周龄时。对BB-DP大鼠和Wistar大鼠(对照)从3至20周龄进行研究。通过评估甲状腺重量和测量每0.01平方毫米甲状腺切片中甲状腺细胞核的数量来研究增生性甲状腺肿的发展。此外,通过免疫组织化学研究白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、单核细胞趋化蛋白-1(MCP-1)和细胞间黏附分子-1(ICAM-1)的原位表达。通过将氚标记胸腺嘧啶核苷([3H]TdR)和溴脱氧尿苷(BrdU)掺入重组的、TSH刺激和非TSH刺激的培养甲状腺滤泡中来测量BB-DP和Wistar甲状腺细胞的体外增殖能力。进一步的体外研究包括测量甲状腺滤泡产生甲状腺素(T4)、三碘甲状腺原氨酸(T3)、甲状腺球蛋白、IL-6、TNF-α和MCP-1的情况。BB-DP大鼠在9至12周龄之间出现了小的增生性甲状腺肿。从增生性BB-DP甲状腺分离的甲状腺细胞的体外增殖率显著低于Wistar甲状腺细胞。这种现象在增生性甲状腺肿发展之前从BB-DP大鼠分离的滤泡中也出现,与相同年龄的Wistar滤泡相比,其产生的T4显著减少,但T3更多。在增生性甲状腺肿发展时及之后,BB-DP滤泡表现出代谢行为改变,与相同年龄的Wistar滤泡和年轻BB-DP大鼠的滤泡相比(在基础条件和TSH刺激下),产生的T4显著更多,但T3量相等。这些BB-DP甲状腺滤泡的体外IL-6产生也增加。在任何年龄,BB-DP和Wistar滤泡之间甲状腺球蛋白和MCP-1的产生没有显著差异。BB-DP或Wistar甲状腺滤泡均不产生TNF-α。免疫组织化学显示在所有采样时间BB-DP和Wistar甲状腺滤泡细胞均表达IL-6。仅当BB-DP甲状腺中有浸润时(限于白细胞,年龄>18周)才表达MCP-1和TNF-α。适度的ICAM-1表达仅限于BB-DP和Wistar甲状腺中的大血管;仅在浸润(BB-DP大鼠)情况下,在这些浸润中的血管和白细胞上发现高ICAM-1表达。在甲状腺内树突状细胞积累时,BB-DP大鼠出现小的增生性甲状腺肿。此时也有体外证据表明甲状腺滤泡向产生更多甲状腺素和IL-6转变。然而,BB-DP甲状腺细胞的体外增殖率异常低(在增生前期和增生期均如此)。在另一种甲状腺自身免疫疾病动物模型——肥胖品系鸡中也描述了类似的自身免疫前期甲状腺生长异常。